0001209191-24-001875.txt : 20240118 0001209191-24-001875.hdr.sgml : 20240118 20240118202429 ACCESSION NUMBER: 0001209191-24-001875 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240118 FILED AS OF DATE: 20240118 DATE AS OF CHANGE: 20240118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CALSADA CRISPINA CENTRAL INDEX KEY: 0001606833 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35670 FILM NUMBER: 24543459 MAIL ADDRESS: STREET 1: C/O AMBRX, INC. STREET 2: 10975 N. TORREY PINES RD. CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Regulus Therapeutics Inc. CENTRAL INDEX KEY: 0001505512 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 264738379 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4224 CAMPUS POINT COURT STREET 2: SUITE 210 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-202-6300 MAIL ADDRESS: STREET 1: 4224 CAMPUS POINT COURT STREET 2: SUITE 210 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2024-01-18 0 0001505512 Regulus Therapeutics Inc. RGLS 0001606833 CALSADA CRISPINA C/O REGULUS THERAPEUTICS 4224 CAMPUS POINT COURT #210 SAN DIEGO CA 92121 0 1 0 0 Chief Financial Officer 0 Common Stock 2024-01-18 4 S 0 5468 1.1906 D 5782 D Sale of shares of common stock to cover tax withholding obligations incurred in connection with the vesting of the restricted stock unit award received by the Reporting Person on 1/11/2023. Christopher Aker, Attorney in Fact 2024-01-18